Pharmacotherapeutic considerations and options for the management of osteoarthritis in women

References

• Zhang Y, Jordan JM. Epidemiology of osteoarthritis. Clin Geriatr Med. 2010;26(3):355–369.
   PubMed Web of Science ®Google Scholar
• Cisternas MG, Murphy L, Sacks JJ, et al. Alternative methods for defining osteoarthritis and the impact on estimating prevalence in a US population-based survey. Arthritis Care Res. 2016. DOI:10.1002/acr.22721
   Web of Science ®Google Scholar
• Torio CM, Moore BJ National inpatient hospital costs: the most expensive conditions by payer, 2013; 2016. doi:10.1377/hlthaff.2015.1194.3
   Google Scholar
• Palazzo C, Nguyen C, Lefevre-Colau MM, et al. Risk factors and burden of osteoarthritis. Ann Phys Rehabil Med. 2016. DOI:10.1016/j.rehab.2016.01.006
   Web of Science ®Google Scholar
• Moskowitz RW. The burden of osteoarthritis: clinical and quality-of-life issues. Am J Manag Care. 2009;15(8):S223–9.
   PubMedGoogle Scholar
• Lohmander LS, Roos EM. Disease modification in OA — will we ever get there? Nat Rev Rheumatol. 2019. DOI:10.1038/s41584-019-0174-1
   Web of Science ®Google Scholar
• Srikanth VK, Fryer JL, Zhai G, et al. A meta-analysis of sex differences prevalence, incidence and severity of osteoarthritis. Osteoarthr Cartil. 2005. DOI:10.1016/j.joca.2005.04.014
   PubMed Web of Science ®Google Scholar
• O’Connor MI. Osteoarthritis of the Hip and Knee: sex and gender differences. Orthop Clin North Am. 2006. DOI:10.1016/j.ocl.2006.09.004
   Web of Science ®Google Scholar
• Hawker GA, Wright JG, Coyte PC, et al. Differences between men and women in the rate of use of Hip and Knee arthroplasty. N Engl J Med. 2002. DOI:10.1056/nejm200004063421405.
   Web of Science ®Google Scholar
• Rosemann T, Laux G, Szecsenyi J. Osteoarthritis: quality of life, comorbidities, medication and health service utilization assessed in a large sample of primary care patients. J Orthop Surg Res. 2007;2:12. Published 2007 Jun 30. .
   PubMedGoogle Scholar
• Woo J, Lau E, Lee P, et al. Impact of osteoarthritis on quality of life in a Hong Kong Chinese population. J Rheumatol. 2004;31(12):2433–8.
   Web of Science ®Google Scholar
• Keefe FJ, Lefebvre JC, Egert JR, et al. The relationship of gender to pain, pain behavior, and disability in osteoarthritis patients: the role of catastrophizing. Pain. 2000. DOI:10.1016/S0304-3959(00)00296-7
   Web of Science ®Google Scholar
• Robinson ME, Gagnon CM, Riley JL, et al. Altering gender role expectations: effects on pain tolerance, pain threshold, and pain ratings. J Pain. 2003. DOI:10.1016/S1526-5900(03)00559-5
   Web of Science ®Google Scholar
• Madry H, Kon E, Condello V, et al. Early osteoarthritis of the knee. Knee Surg Sports Traumatol Arthrosc. 2016. DOI:10.1007/s00167-016-4068-3.
   Google Scholar
• Bay-Jensen AC, Thudium CS, Gualillo O, et al. Biochemical marker discovery, testing and evaluation for facilitating OA drug discovery and development. Drug Discov Today. 2018. DOI:10.1016/j.drudis.2017.10.008
   PubMed Web of Science ®Google Scholar
• Bay-Jensen AC, Thudium CS, Mobasheri A. Development and use of biochemical markers in osteoarthritis: current update. Curr Opin Rheumatol. 2018. DOI:10.1097/BOR.0000000000000467.
   PubMed Web of Science ®Google Scholar
• Sowers MF, Karvonen-Gutierrez CA, Yosef M, et al. Longitudinal changes of serum COMP and urinary CTX-II predict X-ray defined knee osteoarthritis severity and stiffness in women. Osteoarthr Cartil. 2009. DOI:10.1016/j.joca.2009.06.001.
   PubMed Web of Science ®Google Scholar
• Prieto-Alhambra D, Judge A, Javaid MK, et al. Incidence and risk factors for clinically diagnosed knee, hip and hand osteoarthritis: influences of age, gender and osteoarthritis affecting other joints. Ann Rheum Dis. 2014. DOI:10.1136/annrheumdis-2013-203355
   Web of Science ®Google Scholar
• Debi R, Mor A, Segal O, et al. Differences in gait patterns, pain, function and quality of life between males and females with knee osteoarthritis: A clinical trial. BMC Musculoskelet Disord. 2009;10:127. DOI:10.1186/1471-2474-10-127.
   PubMed Web of Science ®Google Scholar
• Maillefert JF, Gueguen A, Monreal M, et al. Sex differences in hip osteoarthritis: results of a longitudinal study in 508 patients. Ann Rheum Dis. 2003. DOI:10.1136/ard.62.10.931.
   Web of Science ®Google Scholar
• Dell’Isola A, Allan R, Smith SL, et al. Identification of clinical phenotypes in knee osteoarthritis: a systematic review of the literature. BMC Musculoskelet Disord. 2016;17(1):425. Published 2016 Oct 12. .
   PubMedGoogle Scholar
• Deveza LA, Melo L, Yamato TP, et al. Knee osteoarthritis phenotypes and their relevance for outcomes: a systematic review. Osteoarthr Cartil. 2017. DOI:10.1016/j.joca.2017.08.009
   Web of Science ®Google Scholar
• Van Spil WE, Kubassova O, Boesen M, et al. Osteoarthritis phenotypes and novel therapeutic targets. Biochem Pharmacol. 2019. DOI:10.1016/j.bcp.2019.02.037
   PubMed Web of Science ®Google Scholar
• Berenbaum F. Deep phenotyping of osteoarthritis: A step forward. Ann Rheum Dis. 2019. DOI:10.1136/annrheumdis-2018-213864
   Web of Science ®Google Scholar
• Felson DT. Identifying different osteoarthritis phenotypes through epidemiology. Osteoarthr Cartil. 2010. DOI:10.1016/j.joca.2010.01.007
   Web of Science ®Google Scholar
• Herrero-Beaumont G, Roman-Blas JA, Castañeda S, et al. Primary osteoarthritis no longer primary: three subsets with distinct etiological, clinical, and therapeutic characteristics. Semin Arthritis Rheum. 2009. DOI:10.1016/j.semarthrit.2009.03.006.
   PubMed Web of Science ®Google Scholar
• STECHER RM. Heberden’s nodes; the clinical characteristic of osteo-arthritis of the fingers. Ann Rheum Dis. 1948. DOI:10.1136/ard.7.1.1
   Web of Science ®Google Scholar
• Spector TD, Cicuttini F, Baker J, et al. Genetic influences on osteoarthritis in women: A twin study. Br Med J. 1996. DOI:10.1136/bmj.312.7036.940
   Google Scholar
• Loughlin J. Genetic epidemiology of primary osteoerthritis. Curr Opin Rheumatol. 2001. DOI:10.1097/00002281-200103000-00004
   PubMed Web of Science ®Google Scholar
• Tachmazidou I, Hatzikotoulas K, Southam L, et al. Identification of new therapeutic targets for osteoarthritis through genome-wide analyses of UK Biobank data. Nat Genet. 2019. DOI:10.1038/s41588-018-0327-1.
   Web of Science ®Google Scholar
• Van der Kraan PM, Van den Berg WB. Chondrocyte hypertrophy and osteoarthritis: role in initiation and progression of cartilage degeneration? Osteoarthr Cartil. 2012. DOI:10.1016/j.joca.2011.12.00332
   Web of Science ®Google Scholar
• Rushton MD, Reynard LN, Barter MJ, et al. Characterization of the cartilage DNA methylome in knee and hip osteoarthritis. Arthritis Rheumatol. 2014. DOI:10.1002/art.38713.
   PubMedGoogle Scholar
• Hussain SM, Cicuttini FM, Alyousef B, et al. Female hormonal factors and osteoarthritis of the knee, hip and hand: a narrative review. Climacteric. 2018. DOI:10.1080/13697137.2017.1421926
   PubMed Web of Science ®Google Scholar
• Herrero-Beaumont G, Roman-Blas JA, Bruyère O, et al. Clinical settings in knee osteoarthritis: pathophysiology guides treatment. Maturitas. 2017. DOI:10.1016/j.maturitas.2016.11.013.
   PubMed Web of Science ®Google Scholar
• Stevens-Lapsley JE, Kohrt WM. Osteoarthritis in women: effects of estrogen, obesity and physical activity. Women’s Heal. 2010. DOI:10.2217/whe.10.38
   PubMedGoogle Scholar
• Liu B, Balkwill A, Cooper C, et al. Reproductive history, hormonal factors and the incidence of hip and knee replacement for osteoarthritis in middle-aged women. Ann Rheum Dis. 2009. DOI:10.1136/ard.2008.095653
   PubMed Web of Science ®Google Scholar
• Jung JH, Bang CH, Song GG, et al. Knee osteoarthritis and menopausal hormone therapy in postmenopausal women: A nationwide cross-sectional study. Menopause. 2019. DOI:10.1097/GME.0000000000001280
   PubMed Web of Science ®Google Scholar
• Roman-Blas JA, Castañeda S, Largo R, et al. Osteoarthritis associated with estrogen deficiency. Arthritis Res Ther. 2009. DOI:10.1186/ar2791
   PubMed Web of Science ®Google Scholar
• Loeser RF. Age-related changes in the musculoskeletal system and the development of osteoarthritis. Clin Geriatr Med. 2010. DOI:10.1016/j.cger.2010.03.002
   PubMed Web of Science ®Google Scholar
• Shane Anderson A, Loeser RF. Why is osteoarthritis an age-related disease? Best Pract Res Clin Rheumatol. 2010. DOI:10.1016/j.berh.2009.08.006
   PubMed Web of Science ®Google Scholar
• Litwic A, Edwards MH, Dennison EM, et al. Epidemiology and burden of osteoarthritis. Br Med Bull. 2013. DOI:10.1093/bmb/lds038
   PubMed Web of Science ®Google Scholar
• Greene MA, Loeser RF. Aging-related inflammation in osteoarthritis. Osteoarthr Cartil. 2015. DOI:10.1016/j.joca.2015.01.008
   Google Scholar
• Bruunsgaard H. A high plasma concentration of tnf-α is associated with dementia in centenarians. J Gerontol - Ser A Biol Sci Med Sci. 1999. DOI:10.1093/gerona/54.7.M357
   PubMed Web of Science ®Google Scholar
• Sanchez-Ramirez DC, van der Leeden M, van der Esch M, et al. Elevated C-reactive protein is associated with lower increase in knee muscle strength in patients with knee osteoarthritis: A 2-year follow-up study in the Amsterdam Osteoarthritis (AMS-OA) cohort. Arthritis Res Ther. 2014. DOI:10.1186/ar4580.
   PubMed Web of Science ®Google Scholar
• Castañeda S, Roman-Blas JA, Largo R, et al. Osteoarthritis: A progressive disease with changing phenotypes. Rheumatol (United Kingdom). 2014. DOI:10.1093/rheumatology/ket247
   Google Scholar
• Felson DT, Anderson JJ, Naimark A, et al. Obesity and knee osteoarthritis. The Framingham Study. Ann Intern Med. 1988. DOI:10.7326/0003-4819-109-1-18
   PubMed Web of Science ®Google Scholar
• Wills AK, Black S, Cooper R, et al. Life course body mass index and risk of knee osteoarthritis at the age of 53 years: evidence from the 1946 British birth cohort study. Ann Rheum Dis. 2012. DOI:10.1136/ard.2011.154021.
   PubMed Web of Science ®Google Scholar
• Reyes C, Leyland KM, Peat G, et al. Association between overweight and obesity and risk of clinically diagnosed Knee, Hip, and hand osteoarthritis: a population-based cohort study. Arthritis Rheumatol. 2016. DOI:10.1002/art.39707.
   Google Scholar
• Wang Y, Simpson JA, Wluka AE, et al. Relationship between body adiposity measures and risk of primary knee and hip replacement for osteoarthritis: A prospective cohort study. Arthritis Res Ther. 2009. DOI:10.1186/ar2636.
   Web of Science ®Google Scholar
• Driban JB, Eaton CB, Lo GH, et al. Association of Knee injuries with accelerated Knee osteoarthritis progression: data from the osteoarthritis initiative. Arthritis Care Res. 2014. DOI:10.1002/acr.22359
   Web of Science ®Google Scholar
• Muthuri SG, McWilliams DF, Doherty M, et al. History of knee injuries and knee osteoarthritis: A meta-analysis of observational studies. Osteoarthr Cartil. 2011. DOI:10.1016/j.joca.2011.07.015
   Web of Science ®Google Scholar
• Felson DT, Zhang Y. An update on the epidemiology of knee and hip osteoarthritis with a view to prevention. Arthritis Rheum. 1998. DOI:10.1002/1529-0131(199808)41:8<1343::AID-ART3>3.0.CO;2-9
   Google Scholar
• Van Meer BL, Meuffels DE, Van Eijsden WA, et al. Which determinants predict tibiofemoral and patellofemoral osteoarthritis after anterior cruciate ligament injury? A systematic review. Br J Sports Med. 2015. DOI:10.1136/bjsports-2013-093258
   PubMed Web of Science ®Google Scholar
• Lohmander LS, Englund PM, Dahl LL, et al. The long-term consequence of anterior cruciate ligament and meniscus injuries: osteoarthritis. Am J Sports Med. 2007. DOI:10.1177/0363546507307396
   PubMedGoogle Scholar
• Lohmander LS, Östenberg A, Englund M, et al. High prevalence of knee osteoarthritis, pain, and functional limitations in female soccer players twelve years after anterior cruciate ligament injury. Arthritis Rheum. 2004. DOI:10.1002/art.20589
   Google Scholar
• Stein V, Li L, Lo G, et al. Pattern of joint damage in persons with knee osteoarthritis and concomitant ACL tears. Rheumatol Int. 2012. DOI:10.1007/s00296-010-1749-y.
   PubMed Web of Science ®Google Scholar
• Prodromos CC, Han Y, Rogowski J, et al. A meta-analysis of the incidence of anterior cruciate ligament tears as a function of gender, sport, and a knee injury-reduction regimen. Arthrosc - J Arthrosc Relat Surg. 2007;23(12):1320–1325.e6.
   Web of Science ®Google Scholar
• Franklin J, Ingvarsson T, Englund M, et al. Association between occupation and knee and hip replacement due to osteoarthritis: A case-control study. Arthritis Res Ther. 2010. DOI:10.1186/ar3033
   Web of Science ®Google Scholar
• Bernard TE, Wilder FV, Aluoch M, et al. Job-related osteoarthritis of the knee, foot, hand, and cervical spine. J Occup Environ Med. 2010. DOI:10.1097/JOM.0b013e3181c40e98
   PubMed Web of Science ®Google Scholar
• Edwards RR, Dworkin RH, Turk DC, et al. Patient phenotyping in clinical trials of chronic pain treatments: IMMPACT recommendations. Pain. 2016. DOI:10.1097/j.pain.0000000000000602.
   Web of Science ®Google Scholar
• Jepsen KJ, Bigelow EMR, Schlecht SH. Women build long bones with less cortical mass relative to body size and bone size compared with men. Clin Orthop Relat Res. 2015;473:2530–2539.
   Web of Science ®Google Scholar
• Lang TF. The bone-muscle relationship in men and women. J Osteoporos. 2011. DOI:10.4061/2011/702735
   PubMedGoogle Scholar
• Hanna FS, Teichtahl AJ, Wluka AE, et al. Women have increased rates of cartilage loss and progression of cartilage defects at the knee than men: A gender study of adults without clinical knee osteoarthritis. Menopause. 2009. DOI:10.1097/gme.0b013e318198e30e.
   PubMed Web of Science ®Google Scholar
• Hame SL, Alexander RA. Knee osteoarthritis in women. Curr Rev Musculoskelet Med. 2013. DOI:10.1007/s12178-013-9164-0
   PubMedGoogle Scholar
• Fairweather D, Frisancho-Kiss S, Rose NR. Sex differences in autoimmune disease from a pathological perspective. Am J Pathol. 2008. DOI:10.2353/ajpath.2008.071008
   Web of Science ®Google Scholar
• Klein SL, Flanagan KL. Sex differences in immune responses. Nat Rev Immunol. 2016. DOI:10.1038/nri.2016.90.
   PubMed Web of Science ®Google Scholar
• Isacson D, Bingefors K. Epidemiology of analgesic use: a gender perspective. Eur J Anaesthesiol. 2002. DOI:10.1097/00003643-200219261-00003
   Web of Science ®Google Scholar
• Elboim-Gabyzon M, Rozen N, Laufer Y. Gender differences in pain perception and functional ability in subjects with knee osteoarthritis. ISRN Orthop. 2012. DOI:10.5402/2012/413105
   PubMedGoogle Scholar
• Karlson EW, Daltroy LH, Liang MH, et al. Gender differences in patient preferences may underlie differential utilization of elective surgery. Am J Med. 1997. DOI:10.1016/S0002-9343(97)00050-8
   PubMed Web of Science ®Google Scholar
• Hawker GA, Wright JG, Coyte PC, et al. Differences between men and women in the rate of use of hip and knee arthroplasty. N Engl J Med. 2000. DOI:10.1056/NEJM200004063421405.
   PubMed Web of Science ®Google Scholar
• Bay-Jensen AC, Thudium CS, Gualillo O, et al. Biochemical marker discovery, testing and evaluation for facilitating OA drug discovery and development. Drug Discov Today. 2018. DOI:10.1016/j.drudis.2017.10.008
   PubMed Web of Science ®Google Scholar
• Bay-Jensen AC, Thudium CS, Mobasheri A. Development and use of biochemical markers in osteoarthritis: current update. Curr Opin Rheumatol. 2018. DOI:10.1097/BOR.0000000000000467
   PubMed Web of Science ®Google Scholar
• Rousseau J-C, Millet M, Crozet M, et al. Association of circulating microRNAs with prevalent and incident osteoarthritis in women: the OFELY study. Osteoarthr Cartil. 2018. DOI:10.1016/j.joca.2018.02.396
   Google Scholar
• Bauer DC, Hunter DJ, Abramson SB, et al. Classification of osteoarthritis biomarkers: a proposed approach. Osteoarthr Cartil. 2006. DOI:10.1016/j.joca.2006.04.001.
   Web of Science ®Google Scholar
• Crofford LJ. Use of NSAIDs in treating patients with arthritis. Arthritis Res Ther. 2013. DOI:10.1186/ar4174
   PubMed Web of Science ®Google Scholar
• Wongrakpanich S, Wongrakpanich A, Melhado K, et al. A comprehensive review of non-steroidal anti-inflammatory drug use in the elderly. Aging Dis. 2018. DOI:10.14336/AD.2017.0306
   Web of Science ®Google Scholar
• Neutel CI, Maxwell CJ, Appel WC. Differences between males and females in risk of NSAID-related severe gastrointestinal events. Pharmacoepidemiol Drug Saf. 1999. DOI:10.1002/(SICI)1099-1557(199912)8:7<501::AID-PDS454>3.0.CO;2-Y
   PubMed Web of Science ®Google Scholar
• Maniar KH, Jones IA, Gopalakrishna R, et al. Lowering side effects of NSAID usage in osteoarthritis: recent attempts at minimizing dosage. Expert Opin Pharmacother. 2018. DOI:10.1080/14656566.2017.1414802.
   PubMed Web of Science ®Google Scholar
• da Costa BR, Reichenbach S, Keller N, et al. Effectiveness of non-steroidal anti-inflammatory drugs for the treatment of pain in knee and hip osteoarthritis: a network meta-analysis. Lancet. 2017. DOI:10.1016/S0140-6736(17)31744-0.
   PubMed Web of Science ®Google Scholar
• Graham GG, Scott KF. Mechanism of action of paracetamol. Am J Ther. 2005. DOI:10.1097/00045391-200501000-00008
   PubMedGoogle Scholar
• Jozwiak-Bebenista M, Nowak JZ. Paracetamol: mechanism of action, applications and safety concern. Acta Pol Pharm - Drug Res. 2014;71(1):11–23.
   PubMed Web of Science ®Google Scholar
• Anderson BJ. Paracetamol (Acetaminophen): mechanisms of action. Paediatr Anaesth. 2008. DOI:10.1111/j.1460-9592.2008.02764.x
   Web of Science ®Google Scholar
• Graham GG, Davies MJ, Day RO, et al. The modern pharmacology of paracetamol: therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings. Inflammopharmacology. 2013. DOI:10.1007/s10787-013-0172-x
   PubMed Web of Science ®Google Scholar
• Towheed T, Maxwell L, Judd M, et al. Acetaminophen for osteoarthritis. Cochrane Database Syst Rev. 2006. DOI:10.1002/14651858.CD004257.pub2
   PubMed Web of Science ®Google Scholar
• Pincus T, Swearingen C, Cummins P, et al. Preference for nonsteroidal antiinflammatory drugs versus acetaminophen and concomitant use of both types of drugs in patients with osteoarthritis. J Rheumatol. 2000;27(4):1020–7.
   Web of Science ®Google Scholar
• Leopoldino AO, MacHado GC, Ferreira PH, et al. Paracetamol versus placebo for knee and hip osteoarthritis. Cochrane Database Syst Rev. 2019. DOI:10.1002/14651858.CD013273.
   PubMed Web of Science ®Google Scholar
• Larson AM, Polson J, Fontana RJ, et al. Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study. Hepatology. 2005. DOI:10.1002/hep.20948.
   PubMed Web of Science ®Google Scholar
• Ramachandran A, Jaeschke H. 2017. Acetaminophen. In: Liver pathophysiology: therapies and antioxidants. DOI:10.1016/B978-0-12-804274-8.00006-0.
   Google Scholar
• Lancaster EM, Hiatt JR, Zarrinpar A. Acetaminophen hepatotoxicity: an updated review. Arch Toxicol. 2015. DOI:10.1007/s00204-014-1432-2
   PubMed Web of Science ®Google Scholar
• DeMik DE, Bedard NA, Dowdle SB, et al. Are we still prescribing opioids for osteoarthritis? J Arthroplasty. 2017. DOI:10.1016/j.arth.2017.07.030
   Web of Science ®Google Scholar
• Sommer C, Welsch P, Klose P, et al. [Opioids in chronic neuropathic pain. A systematic review and meta-analysis of efficacy, tolerability and safety in randomized placebo-controlled studies of at least 4 weeks duration]. Schmerz. 2015;29(1):35–46. DOI:10.1007/s00482-014-1455.
   Web of Science ®Google Scholar
• Krebs EE, Gravely A, Nugent S, et al. Effect of opioid vs nonopioid medications on pain-related function in patients with chronic back pain or hip or knee osteoarthritis pain the SPACE randomized clinical trial. J Am Med Assoc. 2018. DOI:10.1001/jama.2018.0899.
   Web of Science ®Google Scholar
• Jevsevar DS. Treatment of osteoarthritis of the knee: evidence-based guideline, 2nd edition. J Am Acad Orthop Surg. 2013. DOI:10.5435/JAAOS-21-09-571
   Web of Science ®Google Scholar
• Ling W, Mooney L, Hillhouse M. Prescription opioid abuse, pain and addiction: clinical issues and implications. Drug Alcohol Rev. 2011. DOI:10.1111/j.1465-3362.2010.00271.x
   PubMed Web of Science ®Google Scholar
• Upadhyay J, Maleki N, Potter J, et al. Alterations in brain structure and functional connectivity in prescription opioid-dependent patients. Brain. 2010. DOI:10.1093/brain/awq138.
   PubMed Web of Science ®Google Scholar
• Rudd RA, Aleshire N, Zibbell JE, et al. Increases in drug and opioid overdose deaths — United States, 2000–2014. MMWR Morb Mortal Wkly Rep. 2015. DOI:10.15585/mmwr.mm6450a3
   PubMed Web of Science ®Google Scholar
• Agarwal P, Sambamoorthi U. healthcare expenditures associated with depression among individuals with osteoarthritis: post-regression linear decomposition approach. J Gen Intern Med. 2015. DOI:10.1007/s11606-015-3393-4
   PubMed Web of Science ®Google Scholar
• Arendt-Nielsen L, Nie H, Laursen MB, et al. Sensitization in patients with painful knee osteoarthritis. Pain. 2010. DOI:10.1016/j.pain.2010.04.003.
   Web of Science ®Google Scholar
• Bajaj P, Bajaj P, Graven-Nielsen T, et al. Osteoarthritis and its association with muscle hyperalgesia: an experimental controlled study. Pain. 2001. DOI:10.1016/S0304-3959(01)00300-1
   PubMed Web of Science ®Google Scholar
• Havelin J, Imbert I, Cormier J, et al. Central sensitization and neuropathic features of ongoing pain in a rat model of advanced osteoarthritis. J Pain. 2016. DOI:10.1016/j.jpain.2015.12.001
   PubMed Web of Science ®Google Scholar
• Wang ZY, Shi SY, Li SJ, et al. Efficacy and safety of duloxetine on osteoarthritis knee pain: a meta-analysis of randomized controlled trials. Pain Med. 2015. DOI:10.1111/pme.12800.
   Google Scholar
• Chappell AS, Ossanna MJ, Liu-Seifert H, et al. Duloxetine, a centrally acting analgesic, in the treatment of patients with osteoarthritis knee pain: A 13-week, randomized, placebo-controlled trial. Pain. 2009. DOI:10.1016/j.pain.2009.06.024.
   PubMedGoogle Scholar
• Konno S, Oda N, Ochiai T, et al. Randomized, double-blind, placebo-controlled phase III trial of duloxetine monotherapy in Japanese patients with chronic low back pain. Spine (Phila Pa 1976). 2016. (Phila Pa 1976). DOI:10.1097/BRS.0000000000001707.
   Google Scholar
• Sofat N, Harrison A, Russell MD, et al. The effect of pregabalin or duloxetine on arthritis pain: A clinical and mechanistic study in people with hand osteoarthritis. J Pain Res. 2017. DOI:10.2147/JPR.S147640.
   PubMed Web of Science ®Google Scholar
• Chen L, Gong M, Liu G, et al. Efficacy and tolerability of duloxetine in patients with knee osteoarthritis: a meta-analysis of randomised controlled trials. Intern Med J. 2019;49(12):1514–1523.
   PubMed Web of Science ®Google Scholar
• Skinner MH, Kuan HY, Skerjanec A, et al. Effect of age on the pharmacokinetics of duloxetine in women. Br J Clin Pharmacol. 2004. DOI:10.1046/j.1365-2125.2003.01963.x.
   Web of Science ®Google Scholar
• Lobo ED, Quinlan T, O’Brien L, et al. Population pharmacokinetics of Orally administered duloxetine in patients: implications for dosing recommendation. Clin Pharmacokinet. 2009. DOI:10.2165/00003088-200948030-00005
   PubMed Web of Science ®Google Scholar
• Osani MC, Bannuru RR. Efficacy and safety of duloxetine in osteoarthritis: a systematic review and meta-analysis. Korean J Intern Med. 2019;34(5):966–973. .
   PubMed Web of Science ®Google Scholar
• Ananías J, Irarrázaval S. Is duloxetine an alternative in the treatment of osteoarthritis? Medwave. 2017. DOI:10.5867/medwave.2017.08.7063
   Web of Science ®Google Scholar
• Oelke M, Roovers JPWR, Michel MC. Safety and tolerability of duloxetine in women with stress urinary incontinence. BJOG An Int J Obstet Gynaecol. 2006. DOI:10.1111/j.1471-0528.2006.00880.x
   PubMed Web of Science ®Google Scholar
• Greist J, McNamara RK, Mallinckrodt CH, et al. Incidence and duration of antidepressant-induced nausea: duloxetine compared with paroxetine and fluoxetine. Clin Ther. 2004. DOI:10.1016/j.clinthera.2004.09.010
   PubMed Web of Science ®Google Scholar
• Goldstein DJ, Lu Y, Detke MJ, et al. Duloxetine vs. placebo in patients with painful diabetic neuropathy. Pain. 2005. DOI:10.1016/j.pain.2005.03.029
   Web of Science ®Google Scholar
• Wilson S, Argyropoulos S. Antidepressants and sleep: A qualitative review of the literature. Drugs. 2005. DOI:10.2165/00003495-200565070-00003
   PubMed Web of Science ®Google Scholar
• Higgins A, Nash M, Lynch AM. Antidepressant-associated sexual dysfunction: impact, effects, and treatment. Drug Healthc Patient Saf. 2010. DOI:10.2147/DHPS.S7634
   PubMedGoogle Scholar
• Clayton A, Kornstein S, Prakash A, et al. Changes in sexual functioning associated with duloxetine, escitalopram, and placebo in the treatment of patients with major depressive disorder. J Sex Med. 2007. DOI:10.1111/j.1743-6109.2007.00520.x
   Web of Science ®Google Scholar
• Delgado PL, Brannan SK, Mallinckrodt CH, et al. Sexual functioning assessed in 4 double-blind placebo- and paroxetine-controlled trials of duloxetine for major depressive disorder. J Clin Psychiatry. 2005. DOI:10.4088/JCP.v66n0603.
   PubMed Web of Science ®Google Scholar
• Du Souich P. Absorption, distribution and mechanism of action of SYSADOAS. Pharmacol Ther. 2014. DOI:10.1016/j.pharmthera.2014.01.002
   PubMed Web of Science ®Google Scholar
• Dougados M. Symptomatic slow-acting drugs for osteoarthritis: what are the facts? Jt Bone Spine. 2006. DOI:10.1016/j.jbspin.2006.09.008
   Web of Science ®Google Scholar
• Kongtharvonskul J, Anothaisintawee T, McEvoy M, et al. Efficacy and safety of glucosamine, diacerein, and NSAIDs in osteoarthritis knee: A systematic review and network meta-analysis. Eur J Med Res. 2015. DOI:10.1186/s40001-015-0115-7
   PubMed Web of Science ®Google Scholar
• Hochberg MC, Martel-Pelletier J, Monfort J, et al. Combined chondroitin sulfate and glucosamine for painful knee osteoarthritis: A multicentre, randomised, double-blind, non-inferiority trial versus celecoxib. Ann Rheum Dis. 2016. DOI:10.1136/annrheumdis-2014-206792.
   Web of Science ®Google Scholar
• Clegg DO, Reda DJ, Harris CL, et al. Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. N Engl J Med. 2006. DOI:10.1056/NEJMoa052771.
   PubMed Web of Science ®Google Scholar
• Roman-Blas JA, Castañeda S, Sánchez-Pernaute O, et al. CS/GSCombined therapy study group. combined treatment with chondroitin sulfate and glucosamine sulfate shows no superiority over placebo for reduction of joint pain and functional impairment in patients with knee osteoarthritis: a six-month multicenter, randomized, double-blind, placebo-controlled clinical trial. Arthritis Rheumatol. 2017;69:77–85. Erratum in: Arthritis Rheumatol 2017;69:2080.109. .
   PubMed Web of Science ®Google Scholar
• Castañeda S, Roman-Blas JA, Largo R, et al. Subchondral bone as a key target for osteoarthritis treatment. Biochem Pharmacol. 2012;83:315–323.
   PubMed Web of Science ®Google Scholar
• Vaysbrot EE, Osani MC, Musetti MC, et al. Are bisphosphonates efficacious in knee osteoarthritis? A meta-analysis of randomized controlled trials. Osteoarthr Cartil. 2018. DOI:10.1016/j.joca.2017.11.013
   PubMed Web of Science ®Google Scholar
• Davis AJ, Smith TO, Hing CB, et al. Are bisphosphonates effective in the treatment of osteoarthritis pain? A meta-analysis and systematic review. PLoS One. 2013;8(9):e72714. Published 2013 Sep 4. .
   PubMed Web of Science ®Google Scholar
• Xing RL, Zhao LR, Wang PM. Bisphosphonates therapy for osteoarthritis: a meta-analysis of randomized controlled trials. Springerplus. 2016;5(1):1704. Published2016 Oct 3. .
   PubMedGoogle Scholar
• Esenyel M, İçağasıoğlu A, Esenyel CZ. Effects of calcitonin on knee osteoarthritis and quality of life. Rheumatol Int. 2013. DOI:10.1007/s00296-012-2399-z
   PubMed Web of Science ®Google Scholar
• Wen ZH, Tang CC, Chang YC, et al. Calcitonin attenuates cartilage degeneration and nociception in an experimental rat model of osteoarthritis: role of TGF-β in chondrocytes. Sci Rep. 2016. DOI:10.1038/srep28862.
   Web of Science ®Google Scholar
• Vinardell T, Dejica V, Poole AR, et al. Evidence to suggest that cathepsin K degrades articular cartilage in naturally occurring equine osteoarthritis. Osteoarthr Cartil. 2009. DOI:10.1016/j.joca.2008.07.017
   Google Scholar
• Hayami T, Zhuo Y, Wesolowski GA, et al. Inhibition of cathepsin K reduces cartilage degeneration in the anterior cruciate ligament transection rabbit and murine models of osteoarthritis. Bone. 2012. DOI:10.1016/j.bone.2012.03.025
   Web of Science ®Google Scholar
• Karsdal MA, Byrjalsen I, Leeming DJ, et al. Tibolone inhibits bone resorption without secondary positive effects on cartilage degradation. BMC Musculoskelet Disord. 2008. DOI:10.1186/1471-2474-9-153
   Web of Science ®Google Scholar
• Yang PY, Tang CC, Chang YC, et al. Effects of tibolone on osteoarthritis in ovariectomized rats: association with nociceptive pain behaviour. Eur J Pain (United Kingdom). 2014. DOI:10.1002/j.1532-2149.2013.00406.x.
   Google Scholar
• Han W, Fan S, Bai X, et al. Strontium ranelate, a promising disease modifying osteoarthritis drug. Expert Opin Investig Drugs. 2017. DOI:10.1080/13543784.2017.1283403
   Web of Science ®Google Scholar
• Schnitzer TJ, Easton R, Pang S, et al. Effect of tanezumab on joint pain, physical function, and patient global assessment of osteoarthritis among patients with osteoarthritis of the Hip or Knee: a randomized clinical trial. J Am Med Assoc. 2019. DOI:10.1001/jama.2019.8044.
   Web of Science ®Google Scholar
• Hsu YH, Yang YY, Huwang MH, et al. Anti-IL-20 monoclonal antibody inhibited inflammation and protected against cartilage destruction in murine models of osteoarthritis. PLoS One. 2017. DOI:10.1371/journal.pone.0175802.
   Web of Science ®Google Scholar
• Atkinson SM, Bleil J, Maier R, et al. Anti-RANKL treatment inhibits erosive joint destruction and lowers inflammation but has no effect on bone formation in the delayed-type hypersensitivity arthritis (DTHA) model. Arthritis Res Ther. 2016. DOI:10.1186/s13075-016-0931-3.
   PubMed Web of Science ®Google Scholar
• Kon E, Filardo G, Drobnic M, et al. Non-surgical management of early knee osteoarthritis. Knee Surg Sports Traumatol Arthrosc. 2012. DOI:10.1007/s00167-011-1713-8.
   Web of Science ®Google Scholar
• Ayhan E. Intraarticular injections (corticosteroid, hyaluronic acid, platelet rich plasma) for the knee osteoarthritis. World J Orthop. 2014. DOI:10.5312/wjo.v5.i3.351
   PubMedGoogle Scholar
• Kompel AJ, Roemer FW, Murakami AM, et al. Intra-articular corticosteroid injections in the Hip and Knee: perhaps not as safe as we thought? Radiology. 2019. DOI:10.1148/radiol.2019190341
   PubMed Web of Science ®Google Scholar
• Zeng C, Lane NE, Hunter DJ, et al. Intra-articular corticosteroids and the risk of knee osteoarthritis progression: results from the Osteoarthritis Initiative. Osteoarthr Cartil. 2019;27(6):855–862.
   PubMed Web of Science ®Google Scholar
• Jones IA, Chen X, Evseenko D, et al. Nomenclature inconsistency and selective outcome reporting hinder understanding of stem cell therapy for the knee. J Bone Jt Surg Am Vol. 2019. doi:10.2106/JBJS.17.01474.
   Web of Science ®Google Scholar
• Franchi M, Schinko E. Estrogens and bone metabolism. Minerva Ginecol. 1995. DOI:10.1017/cbo9780511545221.008
   PubMedGoogle Scholar
• Xiao YP, Tian FM, Dai MW, et al. Are estrogen-related drugs new alternatives for the management of osteoarthritis? Arthritis Res Ther. 2016. DOI:10.1186/s13075-016-1045-7
   PubMed Web of Science ®Google Scholar